GlassScriptPhysician profile
Michele M Cooper
NPI 1700042256
$5,506.90
in general payments reported to CMS, 2019-2025
31 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,742 · 2020: $319 · 2021: $187 · 2022: $571 · 2023: $642 · 2024: $529 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,054.00 | 2019 | |
| Novo Nordisk INC | $573.83 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $475.19 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $470.32 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $323.02 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.33 | 2019-2025 | Jardiance |
| Abbvie INC. | $224.25 | 2019-2025 | Linzess, Viberzi |
| Novartis Pharmaceuticals Corporation | $211.45 | 2019-2023 | |
| Evofem Biosciences, INC. | $94.49 | 2022-2025 | Solosec, Phexx, Phexxi |
| Exact Sciences Corporation | $83.62 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $80.92 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $73.69 | 2019-2024 | Veozah |
| Edwards Lifesciences Corporation | $64.17 | 2024 | |
| Galderma Laboratories, L.P. | $64.08 | 2020-2021 | |
| Pfizer INC. | $54.23 | 2019-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $41.56 | 2019-2022 | |
| Organon LLC | $38.81 | 2022 | |
| Hologic Sales and Service, LLC | $35.83 | 2019-2023 | Aptima |
| Idorsia Pharmaceuticals US INC | $30.24 | 2023-2024 | Quviviq |
| Corcept Therapeutics | $28.65 | 2025 | Korlym |
| Dexcom, INC. | $26.70 | 2024 | Dexcom G6 Transmitter |
| Integra Lifesciences Corporation | $25.56 | 2023 | Durasorb Monofilament Mesh |
| Inspire Medical Systems, INC. | $23.55 | 2025 | Inspire |
| Shield Therapeutics INC | $19.93 | 2023 | Accrufer |
| Sage Therapeutics, LLC | $18.09 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $18.09 | 2025 | Qelbree |
| Dynavax Technologies Corporation | $16.67 | 2025 | Heplisav-B |
| Asensus Surgical, INC. | $15.54 | 2023 | Senhance |
| Kowa Pharmaceuticals America, INC. | $14.58 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $13.49 | 2019 | |
| Mayne Pharma Commercial LLC | $11.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.